Efficacy and Safety Evaluation Study of Implants With Periodontal Ligament
NCT ID: NCT07302581
Last Updated: 2025-12-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
6 participants
INTERVENTIONAL
2025-06-20
2027-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The main questions it aims to answer are:
* Does the periodontal ligament-integrated implant achieve stable integration with the jawbone at 24 weeks after placement?
* Can this implant reproduce physiological tooth mobility and sensory function similar to natural teeth while maintaining periodontal health?
This is a multicenter, single-arm, exploratory study with approximately six participants.
Participants will:
* Undergo tooth extraction of one single-rooted tooth that meets eligibility criteria.
* Receive immediate placement of a periodontal ligament-integrated implant into the extraction socket.
* Attend scheduled follow-up visits over 48 weeks for assessments including:
* Dental X-rays and clinical examinations to evaluate bone healing, periodontal ligament formation, and implant stability.
* Measurements of tooth mobility, pocket depth, and pain levels.
* Quality of life assessments using a standardized oral health questionnaire.
Researchers will monitor participants for implant integration, safety outcomes, and physiological function restoration over the study period.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The rationale for this study is that preserving and integrating residual PDL tissue may allow the implant to develop a PDL-like attachment, potentially restoring physiological tooth mobility, mechanosensory feedback, and natural load distribution to the alveolar bone. This could enable improved long-term function and compatibility with adjacent natural teeth, particularly in cases where the implant is connected to them.
Participants will undergo immediate implant placement following extraction of a single-rooted tooth (incisor to premolar) that meets inclusion criteria. The implant-abutment assembly is secured temporarily using a fixation device to ensure stability during early healing. The fixation is maintained for approximately 9 weeks, followed by staged removal and functional loading through placement of a superstructure. Throughout the observation period (up to 48 weeks), multiple evaluations will be conducted to assess integration into the jawbone, periodontal attachment formation, bone remodeling, implant mobility, and patient-reported comfort.
Comprehensive radiographic, clinical, and physiological assessments will be performed to monitor healing dynamics, bone response, and periodontal adaptation. Safety will be assessed by recording adverse events related to surgery, device performance, or oral function. Oral hygiene and supportive care will be provided throughout the study.
The findings from this exploratory research are expected to provide foundational data regarding the biological feasibility, mechanical behavior, and clinical safety of PDL-integrated implants as a novel approach for immediate implant placement and restoration of physiological dental function.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Periodontal Ligament-Integrated Implant Placement
Participants undergo preoperative evaluation, including oral examination, CT imaging, and impressions for implant simulation and fabrication. After eligibility confirmation, a single-rooted tooth is extracted using minimally invasive techniques to preserve residual periodontal ligament tissue. A periodontal ligament-integrated implant with an abutment and fixation is immediately placed into the extraction socket and stabilized with dental cement. Sutures are removed after three weeks. The implant remains unloaded for about nine weeks for healing and integration into the jawbone, with periodic radiographic evaluation. A superstructure is then fabricated and placed for controlled occlusal loading. Once integration into the jawbone via regenerated periodontal ligament is confirmed, the fixation is removed and the implant functions independently. Oral care is maintained throughout the study.
Periodontal Ligament-Integrated Implant
The investigational device is a periodontal ligament-integrated implant designed for immediate placement into a tooth extraction socket. Unlike conventional osseointegrated implants, this device utilizes residual periodontal ligament tissue to establish functional attachment and physiological integration with the alveolar bone. The implant-abutment assembly is stabilized with a temporary fixation device for approximately nine weeks, during which integration into the jawbone through the residual periodontal ligament is promoted. After the healing phase, a definitive superstructure is fabricated and placed to allow controlled occlusal loading. Once integration into the jawbone and implant stability are confirmed, the fixation device is removed, and the implant functions independently. The device remains unapproved and is evaluated for safety and efficacy in this study.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Periodontal Ligament-Integrated Implant
The investigational device is a periodontal ligament-integrated implant designed for immediate placement into a tooth extraction socket. Unlike conventional osseointegrated implants, this device utilizes residual periodontal ligament tissue to establish functional attachment and physiological integration with the alveolar bone. The implant-abutment assembly is stabilized with a temporary fixation device for approximately nine weeks, during which integration into the jawbone through the residual periodontal ligament is promoted. After the healing phase, a definitive superstructure is fabricated and placed to allow controlled occlusal loading. Once integration into the jawbone and implant stability are confirmed, the fixation device is removed, and the implant functions independently. The device remains unapproved and is evaluated for safety and efficacy in this study.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* The teeth adjacent to the tooth to be extracted are natural teeth with healthy periodontal tissues, and no abnormalities are found in dental X-rays, CT scans, periodontal pocket examinations, or physiological mobility tests. Also, patients should be able to achieve proper occlusion with opposing teeth.
* Patients aged 18 years or older at the time of consent.
* Patients who have provided written consent to participate in this clinical study and are able to comply with study visits and procedures.
Exclusion Criteria
* Patients undergoing orthodontic treatment or wearing retainers after orthodontic treatment.
* Patients with multiple missing teeth or an edentulous jaw where multiple occlusal support areas of the remaining teeth are missing.
* Patients who have periodontal pockets of 4mm or more around the root of the tooth to be extracted or the teeth adjacent to the tooth to be extracted.
* Patients with bacterial infection or acute inflammation such as periodontitis in the tooth to be extracted.
* Patients with apical periodontitis in the tooth to be extracted.
* Patients who will have two or more consecutive missing teeth or free-end edentulous space due to the extraction of the target teeth.
* Patients who have already had the target tooth extracted.
* Patients for whom extraction of the target tooth is expected to be difficult.
* Patients who are not healthy enough to undergo the tooth extractions and surgical procedures required for implant treatment using this product.
* Patients with abnormal root morphology or position (curved, tilted, etc.) of the tooth to be extracted.
* Patients in whom this product cannot be implanted due to the root size of the tooth to be extracted (root length less than 10 mm, root diameter at the cervical part less than 5.4 mm in long diameter, less than 3.4 mm in short diameter) or malocclusion.
* Patients with open bite.
* Patients with a history of hypersensitivity to the components of this product or similar products.
* Patients with alveolar bone resorption in the area where the implant is to be placed.
* Patients with bleeding disorders. (There is a risk of abnormal bleeding and poor healing of the surgical site).
* Patients with uncontrolled diabetes. (There is a risk of poor healing of the surgical site and increased susceptibility to infection.)
* Patients for whom general oral surgery is contraindicated. (There is a risk that the invasive procedure may worsen the disease, cause recurrence of preexisting conditions, or result in poor healing of the surgical site postoperatively.)
* Patients who undergo radiation therapy or chemotherapy due to malignant tumors, etc. (There is a risk that the surgical site may not heal properly.)
* Patients receiving bisphosphonate therapy.
* Patients who currently smoke.
* Patients who do not understand or cooperate with the treatment.
* Pregnant patients or patients who may be pregnant.
* Any other patient deemed unsuitable for participation in this study by the principal investigator (or co-investigator).
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
OrganTech, Inc.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Shohei Kasugai, PhD
Role: STUDY_DIRECTOR
Minami Tohoku Medical Clinic
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Minami Tohoku Medical Clinic
Kōriyama, Fukushima, Japan
Hillside Akasaka Dental Clinic
Minato-Ku, Tokyo, Japan
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Shohei Kasugai
Role: primary
Takamasa Miyahara
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
jRCTs022240055
Identifier Type: REGISTRY
Identifier Source: secondary_id
OrgT-CPS-001
Identifier Type: -
Identifier Source: org_study_id